IPO Supplementary Protection Certificates – The co-applicants provided authorisations granted in Switzerland in support of their applications but reasoned that these authorisations extended to Liechtenstein and not the rest of the community such that the period of the certificates determined by Article 13(1) should not be calculated on the basis of these authorisations. This was … Continue reading Novartis Ag and Universtiy College London; Novartis Ag and Institute of Microbiology and Epidemiology (Patent): IPO 12 Feb 2003